Massachusetts Prescription Monitoring Program
|
|
- Maud Owen
- 5 years ago
- Views:
Transcription
1 Massachusetts Prescription Monitoring Program PDMP Training and Technical Assistance Center at Brandeis University in partnership with the Bureau of Justice Assistance August 8, 2012 Massachusetts Department of Public Health Bureau of Health Care Safety and Quality Drug Control Program
2 MA PMP Unsolicited Reports Developed for Release to Law Enforcement-Regulatory Agencies N.B. The data from the PMP are only a part of the picture. Information is collected from pharmacies and subject to limitations.
3 Massachusetts Prescription Monitoring Program MA PMP established by joint regulations with the Board of Registration in Pharmacy 1994 staff began presenting DCP developed cases to the Medical Review Group (MRG) for review and guidance on release.
4 Regulatory Authority 105 CMR (4) (a) The Commissioner or a designee may disclose data collected pursuant to 105 CMR to the parties enumerated in 105 CMR (D)(1)(c) through (f) in response to an inquiry or at the initiation of the Commissioner or designee. (b) Disclosure at the initiation of the Commissioner or designee shall be in conformance with any protocols established by the, in consultation with the Medical Review Group, concerning a patient, customer, practitioner or pharmacy potentially engaged in diversion or inappropriate dispensing. In providing such consultation concerning Department initiated disclosure, the Medical Review Group shall review the content and application of the protocols, make recommendations to the Department for effective use of such protocols and as needed review specific instances of Department initiated disclosure. In undertaking such review, the Medical Review Group shall be provided upon request with such pertinent information as needed.
5 Medical Review Group (MRG) Review the content and application of protocols and make recommendations to the Department for effective use of protocols to expedite release of cases. Review specific instances of Department initiated disclosure to make recommendations regarding release of cases.
6 DCP/ MA PMP Initiated Cases Review and analysis of data Patterns raise questions MRG recommendation for referral Law enforcement/reg agency
7 Massachusetts Prescription Monitoring Program Programs employed by PMP staff: Foxpro SQL Diver by Dimensional Insights
8 MA PMP Patient Information Fields PAT07 Last Name Required by MA PMP PAT08 First Name Required by MA PMP PAT09 Middle Name Required by MA PMP PAT10 Name Prefix Required by MA PMP PAT11 Name Suffix Required by MA PMP PAT12 Address Information 1 Required by MA PMP PAT13 Address Information 2 Required by MA PMP PAT14 City Address Required by MA PMP PAT15 State Address Required by MA PMP PAT16 Zip Code Address Required by MA PMP PAT17 Phone Number PAT18 Date of Birth Required by MA PMP PAT19 Gender Code Required by MA PMP PAT20 Species Code Required by MA PMP PAT21 Patient Location Code Required by MA PMP PAT22 Country of Non-U.S. Resident Required by MA PMP PAT23 Name of Animal
9 MA PMP Dispensing Information Fields DSP02 Prescription Number Required by MA PMP DSP03 Date Written Required by MA PMP DSP04 Refills Authorized Required by MA PMP DSP05 Date Filled Required by MA PMP DSP06 Refill Number Required by MA PMP DSP08 Product ID Required by MA PMP DSP09 Quantity Dispensed Required by MA PMP DSP10 Days Supply Required by MA PMP DSP12 Transmission Form of Rx Origin Code Required by MA PMP DSP16 DSP19 Classification Code for Payment Type Electronic Prescription Reference Number Required by MA PMP Required by MA PMP
10 MA PMP Customer Information Fields AIR03 Issuing Jurisdiction Required by MA PMP AIR04 AIR05 AIR06 ID Qualifier of Person Dropping Off or Picking Up Rx ID of Person Dropping Off or Picking Up Rx (Customer ID) Relationship of Person Dropping Off or Picking Up Rx Required by MA PMP Required by MA PMP Required by MA PMP
11 MA PMP Prescriber and Pharmacy Information Required by MA PMP Prescriber NPI when available DEA number Suffix when applicable Pharmacy NCPDP/NABP Provider ID DEA Number Pharmacy Name Pharmacy State Pharmacy Phone Number
12 Protocols for Unsolicited Reports Concerning Possible Criminal Activity Protocol Activity Type Questionable Activity (Threshold Criteria) Forgery (Algorithm)
13 DCP Release of Data by Protocol to DIU Dear Sergeant McQueeney, In a review of the MA Prescription Monitoring Program (PMP) data fourteen records of individuals, that presented as cases of possible questionable activity, were selected for release to the Diversion Investigative Unit. According to Protocol regarding cases of suspected questionable activity by a customer the Department is releasing the data to Diversion Investigative Unit (DIU) for further investigation.
14 Indicators of Questionable Activity Single Customer/Patient Activity - Criteria for number of pharmacies, prescribers, period of time and total number of prescriptions - Supporting information e.g. time overlaps geography - prescriber and pharmacy long acting vs. short acting quantity per prescription
15 Indicators of Questionable Activity cont. Indicators: One customer ID w/ multiple patient names One patient name w/ multiple customer IDs One customer/ patient identifier: both M and F multiple dates of birth
16 Avoiding Detection One prescriber per pharmacy Fill dates would not look questionable to any one prescriber or pharmacy Drugs do not look questionable Dr. Smith is prescriber for Xanax and possibly small amount of oxycodone.
17 DCP Release of Data by Review to BRM Dear Mr. Beattie; In a review and analysis of information from the MA Department of Public Health s (Department) Prescription Monitoring Program (PMP), staff found patterns of prescription data which raised questions regarding the prescribing behavior of a registrant. The members of the Medical Review Group (MRG) reviewed the data and concurred that the records are indicators for possible medical practice issues. The Department and MRG agreed that the registrant s prescribing records for one year should be released to the Board of Registration in Medicine.
18 Practice Issues - Prescriber Prescriber compared to other prescribers number of prescriptions patients: number, gender, age types of controlled substances practice specialty (scope) geography Ds dated, duped, disabled, dishonest, defiant
19 Practice Issues - Prescriber Numbers of prescriptions or dosages units (Someone will always be #1)
20 Practice Issues - Prescriber Scope? Gynecologist prescribing stimulants for males Nurse Midwife prescribing Xanax for males Age Range Nurse Midwife 3 year olds? Pediatrician 41 year olds? Types of and quantities of controlled substances Typical family doctor vs. emergency room doctor
21 Practice Issues - Prescriber Five Ds Dated - Duped Dishonest Defiant Disabled Dated may be easier to determine because year of med school graduation is available from boards and other sources.
22 Additional Resources Folios - foliomed.com physician information includes addresses; phone, fax and s; phone extensions medical specialties with board certification; medical school and year of graduation Boards of Registration Internet searches
23 MA PMP Developing Unsolicited Reports for Release to Law Enforcement / Regulatory Agencies Questions
Interim Commissioner Lauren A. Smith and Members of the Public Health Council
DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JOHN W. POLANOWICZ SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER The Commonwealth of Massachusetts Executive Office of Health and
More informationPrescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationPrescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness
Prescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness Peter Kreiner, Ph.D. Prescription Monitoring Program Center of Excellence at Brandeis University NGA Meeting September
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationSTATE OF TEXAS TEXAS STATE BOARD OF PHARMACY
STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY REQUEST FOR INFORMATION NO. 515-15-0002 PRESCRIPTION DRUG MONITORING PROGRAM Reference: CLASS: 920 ITEM: 05 Posting Date: 12/08/2014 RESPONSE DEADLINE: 01/05/2015
More informationPrescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New York State Information contained in this presentation is accurate as of September 2017 Meet the Speaker Anita Murray, R.Ph., Deputy Director Bureau of Narcotic
More informationEPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: March 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationBold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing
Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing 700.001: Definitions Delegate means an authorized support staff
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE
PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationAuditing Mandatory Electronic. Prescribing in NYS
Auditing Mandatory Electronic Anita Murray, R.Ph. Deputy Director NYS Department of Health Bureau of Narcotic Enforcement Prescribing in NYS September 12, 2017 Bureau of Justice Assistance Harold Rogers
More informationOhio. Contact Information. State Registrant Totals and Population
PDMP name: OARRS Agency responsible: State of Ohio Board of Pharmacy Agency type: Pharmacy Board PDMP email: info@pharmacy.ohio.gov PDMP website: www.ohiopmp.gov Enrollment website: https://ohio.pmpaware.net
More informationAlaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP
Statistics website: Carrillo, Laura - PDMP Manager 550 W. 7th Ave, Ste 1500 Anchorage AK 99501 Office: (907) 269-8404 Fax: (907) 465-2974 Email: laura.carrillo@alaska.gov Alaska PDMP name: AKPDMP PDMP
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
More informationOklahoma. Contact Information. Office: Fax: Statistics
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vogt, Don - PMP Program Manager 419 NE 38th Terrace Oklahoma City OK 73105 Office: (405) 530-3140 Fax: (405) 524-7619 Email: dvogt@obn.state.ok.us
More informationRULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI
RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI This agency was created as an independent state agency
More informationMichigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS
Michigan PDMP name: MAPS PDMP region: Agency responsible: Bureau of Professional Licensing, Drug Monitoring Section Agency type: Professional Licensing Agency PDMP email: BPL-MAPS@michigan.gov PDMP website:
More informationTennessee. Contact Information. State Registrant Totals and Population. PDMP name: CSMD
Statistics website: Bess, D. Todd - Director, CSMD Program 665 Mainstream Drive Nashville TN 37243 Office: (615) 253-1305 Fax: Email: david.bess@tn.gov Tennessee PDMP name: CSMD PDMP region: South Agency
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationReporting Requirements and Exemptions to Reporting
Reporting Requirements and Exemptions to Reporting Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) West Virginia Information contained in this presentation is accurate as of October 2017 What is a Prescription Drug Monitoring Program? A PDMP/PMP is a statewide
More informationNevada. Contact Information. State Registrant Totals and Population
Statistics website: Long, Yenh - Program Administrator 431 W Plumb Ln Reno NV 89509 Office: (775) 687-5694 Fax: (775) 687-5161 Email: ylong@pharmacy.nv.gov Nevada PDMP name: Prescription Controlled Substance
More informationPrescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups
Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups Richard Deyo, MD, MPH Depts. of Family Medicine & Internal Medicine, Oregon Health & Science University Jessica Irvine, MS Acumentra
More informationTennessee. Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Tennessee Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board http://tn.gov/health/topic/csmd-board csmd.admin@tn.gov
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of
More informationPrescription Monitoring Programs - Legislative Trends and Model Law Revision
Prescription Drug Monitoring Programs Training and Technical Assistance Center Webinar Series National Alliance for Model State Drug Laws: Legislative Round-Up July 22, 2015 Prescription Monitoring Programs
More informationDisclosures. Learning Objectives. Pharmacy Law Topics. Spring Seminar 2017
Spring Seminar 2017 prescribing authority Controlled substance Privacy Pharmacy Law Topics Charlie Mollien, PharmD, JD, MS Director of Pharmacy Compliance & Privacy Officer Meijer Disclosures Charlie Mollien
More informationPrescription Monitoring Program State Profiles - Texas
Prescription Monitoring Program State Profiles - Texas Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Shauna K. White, Pharm.D, MS Executive Director Board of Pharmacy Program Manager - Pharmaceutical Control Division September 17, 2016 Objectives
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationMassachusetts. Contact Information. State Registrant Totals and Population. PDMP name: MA Prescription Monitoring Program
Massachusetts PDMP name: MA Prescription Monitoring Program PDMP region: Agency responsible: Department of Public Health Agency type: Department of Health PDMP email: mapmp.dph@massmail.state.ma.us PDMP
More informationReport of the Task Force on Prescription Monitoring Program Standards
Report of the Task Force on Prescription Monitoring Program Standards Members Present: Gay Dodson (TX), chairperson; John Dorvee (ME); Danna Droz (OH); Allen F. Dulwick (OR); William Fitzpatrick (MO);
More informationTechnical Assistance Guide. Enhancing PDMPs: A Comparison of Changes 2010 to 2016
Technical Assistance Guide Enhancing PDMPs: A Comparison of Changes 2010 to 2016 December 2016 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES MASSACHUSETTS
PRESCRIPTION MONITORING PROGRAM STATE PROFILES MASSACHUSETTS Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationColorado. Contact Information
Colorado PDMP name: Prescription Drug Monitoring Program PDMP region: Agency responsible: Colorado State Board of Pharmacy Agency type: Pharmacy Board PDMP email: pdmpinqr@state.co.us PDMP website: https://www.colorado.gov/pacific/dora/pdmp
More informationNEW MEXICO PRACTITIONER S MANUAL
NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us
More informationPrescription Monitoring Program State Profiles - Pennsylvania
Prescription Monitoring Program State Profiles - Pennsylvania Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationPayment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:
Your Rx Pharmacy Notice of our privacy practices THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationMississippi. Contact Information. State Registrant Totals and Population
Statistics website: Mueller, Stephanie - PMP Director 6360 I-55 North, Suite 400 Jackson, MS 39211 Office: (601) 899-0138 Fax: (601) 899-8904 Email: smueller@mbp.ms.gov Mississippi PDMP name: MS PMP Agency
More informationPrescription Monitoring Program:
Massachusetts Department of Public Health Prescription Monitoring Program: The Massachusetts Prescription Monitoring Tool (MassPAT) November 1, 2016 Goals of the Session Understand the mission and responsibilities
More informationLegal Issues in Managing Opioid Abuse. Gwen Dayton, JD
Legal Issues in Managing Opioid Abuse Gwen Dayton, JD Faculty Disclosure It is the policy of the Oregon Hospice Association to insure balance, independence, objectivity, and scientific rigor in all its
More informationPrescription Monitoring Program State Profiles - Michigan
Prescription Monitoring Program State Profiles - Michigan Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationSENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED APRIL, 0 Sponsored by: Senator LORETTA WEINBERG District (Bergen) Senator JOSEPH F. VITALE District (Middlesex) Senator JAMES W. HOLZAPFEL District
More informationThe Wisconsin epdmp:
The Wisconsin epdmp: Frequently Asked Questions Pursuant to 2015 Wisconsin Act 266, effective April 1, 2017, Wisconsin-licensed physicians and other prescribers must review a patient s records from Wisconsin
More informationAdvancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans
Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans Jill Strykowski and Michelle Aytay MPhA Public Affairs Co Chairs, PPAJTF Session Objectives Outline the outcomes from the 2016 Legislative
More informationInstyMeds Prescription Writer Tutorial
InstyMeds Prescription Writer Tutorial July 2014 Log in to the InstyMeds Prescription Writer tool Important messages announcing the latest enhancements and notifications are located here. 1. Type in Username
More informationEvidence-Based Practices to Optimize Prescriber Use of PDMPs
Evidence-Based Practices to Optimize Prescriber Use of PDMPs Sheri Lawal, MPH, CHES Senior Associate, Substance Use Prevention and Treatment Initiative, The Pew Charitable Trusts Thomas Clark Research
More informationPfizer Patient Assistance Program: Instructions for Group D Enrollment Form
Pfizer Patient Assistance Program: Instructions for Group D Enrollment Form This enrollment form is for patients who would like to apply to receive Lyrica (pregabalin) or Lyrica CR (pregabalin) extended
More informationTechnical Assistance Guide. Prescriber Report Cards
Technical Assistance Guide Prescriber Report Cards Revised February 17, 2017 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance
More informationLEMTRADA Services Form
For Patients to Complete LEMTRADA Services Form Instructions for healthcare providers enrolling patients in One to One To enroll in One to One Support Services for LEMTRADA (alemtuzumab), you and your
More informationPrescription Monitoring Program State Profiles - Kentucky
Prescription Monitoring Program State Profiles - Kentucky Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationNew Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP
Statistics website: Ryba, Peter, PharmD - PMP Director 5500 San Antonio Drive NE, Suite C Albuquerque NM 87109 Office: (505) 222-9818 Fax: (505) 222-9845 Email: peter.ryba@state.nm.us New Mexico PDMP name:
More informationNorth Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: North Carolina PDMP region: South North Carolina Department
More informationSteps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.
Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels Nick Snyder, Esq. How Can We Impact Inappropriate Over-Prescribing of Opioids in Maine? What have other States or Organizations
More informationApplication for Massachusetts Controlled Substances Registration for Advanced Practice Registered Nurses and Physician Assistants
Commonwealth of Massachusetts Department of Public Health, Bureau of Health Professions Licensure Drug Control Program 239 Causeway Street, Suite 500, Boston, MA 02114 Telephone 617-973-0949 Fax 617-753-8233
More informationKentucky. Kentucky Cabinet for Health and Family Services Office of Inspector General
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: Kentucky Kentucky Cabinet for Health and Family Services
More informationHow to Get the Most Out of Prescription Drug Monitoring Programs
How to Get the Most Out of Prescription Drug Monitoring Programs Target Audience: Pharmacists and Pharmacy Technicians ACPE#: 0202-0000-18-019-L03-P/T Activity Type: Knowledge-based Disclosures I own 40
More informationPuerto Rico. Contact Information. State Registrant Totals and Population. PDMP name: PR PDMP
Statistics website: Rodriguez, Cieni - Program Manager Carr. No. 2 Km 8.2, Bo. Juan Sanchez Bayamon, PR 00960 Office: (787) 763-7575 Fax: (787) 763-3152 Email: cieni.rodriguez@assmca.pr.gov Puerto Rico
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationChapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)
Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory) By: Katie Blair, PharmD, RPh Author Disclosure: Katie Blair and Elite Professional Education, LLC do not have any actual or potential
More informationAMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:
*LRB00RLC00a* Rep. Cynthia Soto Filed: //0 000SB0ham00 LRB0 0 RLC 00 a AMENDMENT TO SENATE BILL AMENDMENT NO.. Amend Senate Bill, AS AMENDED, by replacing everything after the enacting clause with the
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationGeorgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018
Georgia DPH Prescription Title Drug Heading Monitoring Program Program Sheila Pierce April 2018 What is the PDMP? Legislative Mandates Registration Requirements How to use the PDMP Next Steps for Prescribers
More informationPRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS)
PRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS) Presenters Connecticut Department of Consumer Protection, Prescription Monitoring Program Nana
More informationOREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS
OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS DIVISION 121 PHARMACEUTICAL SERVICES Non-Medicaid Rules Prescription Drug Monitoring Program 410-121-4000 Purpose The purpose of the Prescription
More informationChapter 13 Section 1
Program Integrity Chapter 13 Section 1 Revision: 1.0 CONTRACTOR'S PROGRAM INTEGRITY (PI) RESPONSIBILITY 1.1 The contractor shall incorporate into its organizational management philosophy a published corporate
More informationCHAPTER 15 F425 - PHARMACY SERVICES THE MEDICATION AUDIT TRAIL (ORDERING, RECEIVING AND DISPOSITION OF MEDICATION) 15.1
CHAPTER 15 F425 - PHARMACY SERVICES THE MEDICATION AUDIT TRAIL (ORDERING, RECEIVING AND DISPOSITION OF MEDICATION) 15.1 THE PRESCRIPTION AUDIT TRAIL I. Regulatory Overview STATE 59A-4.112 Florida Nursing
More informationBJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018
BJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018 BJA Update Tara Kunkel Senior Drug Policy Advisor IPA Bureau of Justice Assistance U.S. Department of Justice BJA Grant Project Update: Washington
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 0 S SENATE BILL 0* Health Care Committee Substitute Adopted /1/ Short Title: Health-Local Confinement/Vet. Controlled Sub. (Public) Sponsors: Referred to: May,
More informationPharmacy Compliance: Beyond Med Errors. Overview
Pharmacy Compliance: Beyond Med Errors Daniel P. Fitzgerald, Senior Attorney Litigation & Regulatory Law Department Walgreen Co. James S. Mathis, Esq., Nashville, TN Overview Med Errors & Controlled Substances
More informationMTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview
MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview Today s Speaker Dan Rodriguez, RPh, BPharm Sr. Associate Network Performance OutcomesMTM Learning Objectives - Define Medication
More informationPRESCRIBING IN NEVADA
PRESCRIBING IN NEVADA An Inside Look at Changes to Nevada Laws Surrounding Prescribing Controlled Substances for the Treatment of Pain These changes to Nevada law do not impact the authority of practitioners
More informationPharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.
Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A. Objectives: Pharmacist and Pharmacy Technician Learning Objectives: At the end of this activity, participants
More informationIdaho Pharmacy Law: Developments and Practical Applications
Idaho Pharmacy Law: Developments and Practical Applications Alex J. Adams, PharmD, MPH Executive Director Idaho State Board of Pharmacy Alex.Adams@bop.idaho.gov @alexadamsrph In support of improving patient
More informationFrequently Asked Questions
1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation
More informationPrescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017
Prescription Drug Monitoring Program (PDMP) LOUISIANA Information contained in this presentation is accurate as of September 2017 Meet the Speaker Julie W. Breithaupt PharmD, MBA President Louisiana Pharmacists
More informationK-TRACS: Review of Program Data and a Qualitative Assessment Study
K-TRACS: Review of Program Data and a Qualitative Assessment Study Amy Curry, MD Clinical Assistant Professor University of Kansas School of Medicine - Wichita Department of Family and Community Medicine
More informationMcConnell AFB Pharmacy Frequently Asked Questions
McConnell AFB Pharmacy Frequently Asked Questions (click the link in blue to be directed to the answer) 1. What are the pharmacy hours? 2. What are your busiest hours in the pharmacy? 3. When can I process
More informationNOVARTIS ONCOLOGY SERVICE REQUEST
Patient First Name Patient Last Name Patient of Birth NOVARTIS ONCOLOGY SERVICE REQUEST FORM FOR PATIENT SUPPORT For more information, please call 1-800-282-7630 from 9:00 am to 8:00 pm ET, Monday through
More informationVersion 5010 Errata Provider Handout
Version 5010 Errata Provider Handout 5010 Bringing Clarity & Consistency To Your Electronic Transactions Benefits Transactions Impacted Changes Impacting Providers While we have highlighted the HIPAA Version
More informationNOVARTIS ONCOLOGY SERVICE REQUEST
NOVARTIS ONCOLOGY SERVICE REQUEST FORM (CONT) Patient First Name Patient Last Name Patient of Birth NOVARTIS ONCOLOGY SERVICE REQUEST 5. PRESCRIPTION INFORMATION (TO BE COMPLETED BY PRESCRIBER) FORM FOR
More informationDelegator Dashboard User Guide
Delegator Dashboard User Guide ULP Delegator Dashboard Technical Guide This guide is intended for a Prescriber or Pharmacist who is utilizing Delegates to facilitate PDMP data access. A separate guide
More informationMaryland. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Maryland Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationChapter 52. Board of Pharmacy.
Chapter 52. Board of Pharmacy. (Words in boldface and underlined indicate language being added; words [CAPITALIZED AND BRACKETED] indicate language being deleted. Complete new sections are not in boldface
More informationPrescription Writer/ eprescribe
Prescription Writer is an application within Acute Care that allows providers to do the following: 1. Create and maintain a list of home medications 2. Electronically transmit new prescriptions 3. Convert
More informationMandatory Electronic Prescribing in NYS
Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting August 16-19, 2016 Anita Murray, R.Ph. Deputy Director NYS Department of Health Bureau of Narcotic Enforcement
More informationPurpose: To establish guidelines for the clinical practice of Non-Physician Medical Practitioners (NPMP).
Purpose: To establish guidelines for the clinical practice of Non-Physician Medical Practitioners (NPMP). Policy: The Central California Alliance for Health (the Alliance) requires all NPMPs to meet the
More informationTypes of Authorized Recipients Probation/Parole Officers or the Department of Corrections
Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office
More informationRULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION
RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION CHAPTER 0800-02-25 WORKERS COMPENSATION MEDICAL TREATMENT TABLE OF CONTENTS 0800-02-25-.01 Purpose and Scope
More informationHealth Information Exchange: Substance Abuse Patient Records March 3, 2016
Health Information Exchange: Substance Abuse Patient Records March 3, 2016 Jody Denson, MPA, PMP, Kansas Health Information Network Cristine Deibler, LMSW, CHC, Johnson County Mental Health Center Conflict
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 9:45 am 11:15 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 10 Title: Activity Type: Speaker: How to Be
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationManitoba Prescribing Practices Program Pharmacist Questions and Answers
College of Pharmacists of Manitoba 200 Tache Avenue, Winnipeg, Manitoba R2H 1A7 Phone (204) 233-1411 Fax: (204) 237-3468 E-mail: info@cphm.ca Website: www.cphm.ca Manitoba Prescribing Practices Program
More informationNATIONWIDE CHILDREN S HOSPITAL / COLUMBUS, OHIO ADVANCED PRACTICE REGISTERED NURSE STANDARD CARE ARRANGEMENT (SCA)
NATIONWIDE CHILDREN S HOSPITAL / COLUMBUS, OHIO ADVANCED PRACTICE REGISTERED NURSE STANDARD CARE ARRANGEMENT (SCA) I. STATEMENT OF PURPOSE A. Advanced Practice Registered Nurses (APRNs) at Nationwide Children
More informationPATIENT NOTICE. If you are already taking any of the above medications, your provider may want to talk to you about alternative treatments.
PATIENT NOTICE Our goal at is to provide quality medical care. Because of our concern for your health and well-being, there are certain types of medications we may not be able to prescribe to you. Examples
More informationE Prescribing E Rx: Background. E Rx: Definition. Rebecca H. Wartman, O.D.
E Prescribing 2011 E Rx 2011 is presented by Rebecca H. Wartman, O.D. Practice Advancement Committee Member, Clinical and Practice Advancement Group American Optometric Association E Rx: Background Electronic
More informationThe Challenges of Interstate Data Sharing
The Challenges of Interstate Data Sharing 2016 Harold Rogers Prescription Drug Monitoring Program National Meeting August 17 19, 2016 Background The Challenges of Interstate Data Sharing Prescription Monitoring
More informationALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
Nursing Chapter 610-X-5 ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05
More informationIdaho Pharmacy Law: Update and Practical Applications
Idaho Pharmacy Law: Update and Practical Applications Alex J. Adams, PharmD, MPH Executive Director Idaho State Board of Pharmacy Alex.Adams@bop.idaho.gov @alexadamsrph In support of improving patient
More information